Nitzan Rosenfeld

This study uses ctDNA from metastatic breast cancer patients and a Bayesian model to predict treatment response and progression-free survival, outperforming alternative methods.

This study identifies and integrates three genome-wide features of cfDNA fragmentation to enhance ctDNA detection in ovarian cancer patients.

The paper detects circulating tumor DNA in plasma and urine of glioma patients using sequencing guided by tumor mutations.

The paper shows that selecting short DNA fragments in plasma improves the detection of circulating tumour DNA by enriching mutated DNA, enabling identification of copy number alterations previously undetected.